The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...

Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.

The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

Colorado Gov. Jared Polis (D) is facing backlash following a comment he made about being “excited” by President-elect tapping ...

More about Robert F Kennedy Jr, Trump’s health secretary pick who is sceptical of vaccines, the FDA and fluoride.